Jiangsu CoWin Biotech Co., Ltd. (SHA:688426)
China
· Delayed Price · Currency is CNY 23.54
+0.57 (2.48%)
At close: Mar 10, 2026
Jiangsu CoWin Biotech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Net Income | - | -157.21 | -84.41 | 159.26 | 125.85 | Upgrade
|
| Depreciation & Amortization | - | 38.83 | 33.55 | 23.25 | 15.73 | Upgrade
|
| Other Amortization | - | 4.33 | 3.69 | 3.06 | 2.31 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.19 | -1.24 | 0.51 | -1.29 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 3.44 | 4.27 | 0.06 | 0.03 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -18.21 | -26.71 | -7.94 | -7.57 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 21.67 | 20.8 | 9.51 | 1.6 | Upgrade
|
| Other Operating Activities | - | 3.83 | 8.94 | 16.85 | 3.13 | Upgrade
|
| Change in Accounts Receivable | - | -11.84 | 52.74 | -97.15 | -16.08 | Upgrade
|
| Change in Inventory | - | -19.48 | 17.55 | -23.29 | -9.6 | Upgrade
|
| Change in Accounts Payable | - | 21.91 | -43.75 | 14.18 | 20.47 | Upgrade
|
| Change in Other Net Operating Assets | - | 2.9 | 16.33 | 13.15 | 8.43 | Upgrade
|
| Operating Cash Flow | - | -113.26 | -11.72 | 107.37 | 144.5 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | -25.70% | 32.70% | Upgrade
|
| Capital Expenditures | - | -48.41 | -159.22 | -100.38 | -124.39 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.2 | 1.01 | 0.01 | 0.08 | Upgrade
|
| Cash Acquisitions | - | -13.83 | - | -5.21 | - | Upgrade
|
| Investment in Securities | - | 121.31 | -479 | -165 | 68.6 | Upgrade
|
| Other Investing Activities | - | 14.89 | 16.29 | 6.77 | 8.71 | Upgrade
|
| Investing Cash Flow | - | 74.16 | -620.91 | -263.81 | -47 | Upgrade
|
| Long-Term Debt Issued | - | 6 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -14.4 | -7.57 | -5.31 | -4.54 | Upgrade
|
| Net Debt Issued (Repaid) | - | -8.4 | -7.57 | -5.31 | -4.54 | Upgrade
|
| Issuance of Common Stock | - | 3.06 | - | 1,083 | - | Upgrade
|
| Repurchase of Common Stock | - | -43.66 | - | - | - | Upgrade
|
| Common Dividends Paid | - | -3.9 | -50.73 | - | - | Upgrade
|
| Other Financing Activities | - | - | 6 | -19.27 | -3.22 | Upgrade
|
| Financing Cash Flow | - | -52.9 | -52.3 | 1,058 | -7.76 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 0.21 | 0.64 | 1.79 | -0.77 | Upgrade
|
| Net Cash Flow | - | -91.79 | -684.29 | 903.72 | 88.98 | Upgrade
|
| Free Cash Flow | - | -161.67 | -170.94 | 6.99 | 20.11 | Upgrade
|
| Free Cash Flow Growth | - | - | - | -65.25% | -78.93% | Upgrade
|
| Free Cash Flow Margin | - | -128.44% | -99.77% | 1.34% | 5.94% | Upgrade
|
| Free Cash Flow Per Share | - | -1.45 | -1.52 | 0.07 | 0.24 | Upgrade
|
| Cash Income Tax Paid | - | 5.66 | 23.45 | 36.72 | 17.62 | Upgrade
|
| Levered Free Cash Flow | - | -127.04 | -115.19 | -38.17 | -9.99 | Upgrade
|
| Unlevered Free Cash Flow | - | -126.16 | -114.13 | -36.96 | -8.79 | Upgrade
|
| Change in Working Capital | - | -9.75 | 29.39 | -97.19 | 4.71 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.